Press "Enter" to skip to content

New patent for Teva Pharm drug ARMONAIR DIGIHALER

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug ARMONAIR DIGIHALER

Annual Drug Patent Expirations for ARMONAIR+DIGIHALER
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER

Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting this drug.

Drug patent litigation for ARMONAIR DIGIHALER.

This drug has three hundred and sixty patent family members in thirty-four countries.

The generic ingredient in ARMONAIR DIGIHALER is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug ARMONAIR DIGIHALER
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions